The Chemical, Biotechnology & Pharmaceutical Practice of Foley serves the diverse needs of enterprises looking to meet the challenges of a competitive, dynamic marketplace.For more than 25 years, our Chemical, Biotechnology & Pharmaceutical attorneys have worked with clients to secure strong patents and trademarks throughout the world, and have been involved in all types of ex parte and inter partes proceedings. Foley attorneys have provided both general corporate representation and specific intellectual property (IP) counsel for our clients — many of whom are industry leaders — in the chemical, pharmaceutical, and biotech industries.
In serving as IP counsel for chemical, biotechnology, and pharmaceutical companies, Foley has advised on state and federal regulatory compliance, assisted in inquiries and investigations, and guided applications through the permitting and approval process, including hearings and documentation requirements.
The legal solutions we have provided to our clients include:
U.S. and foreign patent procurement
Due diligence in mergers and acquisitions and financing transactions
Licensing and technology transfer
Patent enforcement
Patent portfolio management
Risk assessment and patent analysis
Defense of infringement claims
Pharmacology
Vaccine development
Gene therapy technologies
Diagnostic medicine
Stem cell technologies
Personalized medicine technologies
Drug delivery and design
Immunology and virology
Antibodies
Biomedical research and development
Chemical engineering
Organic and inorganic chemistry
Small molecule chemistry
Chiral chemistry
Metallurgy
Semiconductor and superconductor materials
Fertilizers
Polymers
Enzymes
Pharmaceutical formulations and delivery systems
Recognizing the entire product life cycle, Foley attorneys are experienced working with regulatory affairs — including issues involving the U.S. Food and Drug Administration (FDA), U.S. Environmental Protection Agency (EPA), United States Department of Agriculture (USDA), and health-care-related entities such as the Centers for Medicare and Medicaid Services (CMS) and the Office of Inspector General (OIG) — as well as corporate finance and securities law, taxation, international trade issues.
In representing our international clients, attorneys in the Chemical, Biotechnology & Pharmaceutical Practice also structure joint ventures, facilitate acquisitions, counsel on multinational transactions, secure public and private financing, surmount regulatory and legislative hurdles, and evaluate market opportunities.
